We are live on
!
Find out more
PM
Ponoi Management Portfolio holdings
AUM
$73.2M
1-Year Est. Return
23.44%
This Fund
S&P 500
This Quarter
Est. Return
+27.82%
1 Year Est. Return
-23.44%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$175M
AUM Growth
–
Cap. Flow
+$169M
Cap. Flow
% of AUM
96.72%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
5
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
CNST
Constellation Pharmaceuticals, Inc.
CNST
|
+$47.3M |
| 2 |
RAPT
RAPT Therapeutics
RAPT
|
+$43.5M |
| 3 |
NGM
NGM Biopharmaceuticals, Inc. Common Stock
NGM
|
+$28.4M |
| 4 |
Revolution Medicines
RVMD
|
+$27.1M |
| 5 |
Nurix Therapeutics
NRIX
|
+$22.7M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNST
1
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $54.2M | 30.99% |
+1,880,623
| New | +$47.3M |
|
|
NGM
2
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $39.4M | 22.52% |
+1,298,908
| New | +$28.4M |
|
|
RAPT
3
DELISTED
RAPT Therapeutics
RAPT
| $31.6M | 18.07% |
+199,927
| New | +$43.5M |
|
|
4
Revolution Medicines
RVMD
$39.7B
| $27.1M | 15.52% |
+685,011
| New | +$27.1M |
|
|
5
Nurix Therapeutics
NRIX
$2.39B
| $22.6M | 12.91% |
+686,274
| New | +$22.7M |
|
Similar funds
RC
WM
NVPX
FFMBT
SMC
CCM
RA
GI